SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products
11 juni, 14:00
SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products
PR Newswire
SURPRISE, Ariz., June 11, 2025
Strategic Partnership Expands National Reach and Accelerates Retail & Dealer Access Across Rural America
SURPRISE, Ariz. , June 11, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control for managing animal pest populations, today announced a distribution agreement with Bradley Caldwell , Inc. (BCI), a premier wholesale distributor serving over 8,000 farm, ranch, hardware, and pet supply dealers across the United States. This new partnership significantly expands SenesTech's national distribution footprint and brings Evolve™ Rodent Birth Control directly to the hands of rural retailers and independent dealers who serve America's agricultural communities.
" Bradley Caldwell is an ideal partner to help us scale Evolve's presence in core markets where rodent infestations are not only common, but extremely costly," said Joel Fruendt , CEO of SenesTech. "Their trusted relationships and deep penetration into rural retail channels align perfectly with our mission to provide safe, effective, and sustainable rodent control to every corner of the country."
Founded in 1930 and headquartered in Hazleton, Pennsylvania , BCI is one of the most respected distributors in the rural retail space. The company offers an extensive portfolio of farm and home products, with a longstanding reputation for reliability and customer service. Their robust logistics network and dedicated field teams support independent stores in delivering high-value, in-demand solutions to local communities.
Strategic Benefits to SenesTech and BCI Customers:
- Accelerated Market Penetration: Evolve will now be more accessible in underserved markets where traditional rodenticides face resistance or regulatory limits.
- Product Differentiation: BCI customers can offer a scientifically-backed, humane alternative to poison – enhancing their competitive edge.
- Sales Momentum: This partnership supports SenesTech's long-term growth strategy, with anticipated revenue increases from expanded retail sales and new customer acquisition.
This agreement underscores SenesTech's continued execution on its channel expansion and commercialization roadmap, making Evolve a widely available, easy-to-deploy solution in both professional and consumer markets.
BCI's initial order represents the largest distributor stocking order the Company has received.
About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest ® , the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve Rat and Evolve Mouse, EPA-designated minimum risk contraceptives for rodents, reflecting our mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.
For more information visit https://senestech.com/ .
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that the new partnership with BCI expands our national distribution footprint and brings Evolve Rodent Birth Control directly to the hands of rural retailers and independent dealers who serve America's agricultural communities; our belief that Bradley Caldwell is an ideal partner to help us scale Evolve's presence in core markets where rodent infestations are not only common, but extremely costly; our belief that BCI's trusted relationships and deep penetration into rural retail channels align perfectly with our mission to provide safe, effective, and sustainable rodent control to every corner of the country; our belief that Evolve will now be more accessible in underserved markets; our belief that the partnership with BCI supports our long-term growth strategy, with anticipated revenue increases from expanded retail sales and new customer acquisition; and our belief that the BCI agreement underscores our continued execution on our channel expansion and commercialization roadmap, making Evolve a widely available, easy-to-deploy solution in both professional and consumer markets. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 . All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise .
Contact Information:
Investors:
Robert Blum , Lytham Partners, LLC
(602) 889-9700
senestech@lythampartners.com
Marketing:
Rochelle Paulet , Director of Marketing, SenesTech, Inc.
(928) 779-4143 x814
SOURCE SenesTech, Inc.
SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products
11 juni, 14:00
SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products
PR Newswire
SURPRISE, Ariz., June 11, 2025
Strategic Partnership Expands National Reach and Accelerates Retail & Dealer Access Across Rural America
SURPRISE, Ariz. , June 11, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control for managing animal pest populations, today announced a distribution agreement with Bradley Caldwell , Inc. (BCI), a premier wholesale distributor serving over 8,000 farm, ranch, hardware, and pet supply dealers across the United States. This new partnership significantly expands SenesTech's national distribution footprint and brings Evolve™ Rodent Birth Control directly to the hands of rural retailers and independent dealers who serve America's agricultural communities.
" Bradley Caldwell is an ideal partner to help us scale Evolve's presence in core markets where rodent infestations are not only common, but extremely costly," said Joel Fruendt , CEO of SenesTech. "Their trusted relationships and deep penetration into rural retail channels align perfectly with our mission to provide safe, effective, and sustainable rodent control to every corner of the country."
Founded in 1930 and headquartered in Hazleton, Pennsylvania , BCI is one of the most respected distributors in the rural retail space. The company offers an extensive portfolio of farm and home products, with a longstanding reputation for reliability and customer service. Their robust logistics network and dedicated field teams support independent stores in delivering high-value, in-demand solutions to local communities.
Strategic Benefits to SenesTech and BCI Customers:
- Accelerated Market Penetration: Evolve will now be more accessible in underserved markets where traditional rodenticides face resistance or regulatory limits.
- Product Differentiation: BCI customers can offer a scientifically-backed, humane alternative to poison – enhancing their competitive edge.
- Sales Momentum: This partnership supports SenesTech's long-term growth strategy, with anticipated revenue increases from expanded retail sales and new customer acquisition.
This agreement underscores SenesTech's continued execution on its channel expansion and commercialization roadmap, making Evolve a widely available, easy-to-deploy solution in both professional and consumer markets.
BCI's initial order represents the largest distributor stocking order the Company has received.
About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest ® , the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve Rat and Evolve Mouse, EPA-designated minimum risk contraceptives for rodents, reflecting our mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.
For more information visit https://senestech.com/ .
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that the new partnership with BCI expands our national distribution footprint and brings Evolve Rodent Birth Control directly to the hands of rural retailers and independent dealers who serve America's agricultural communities; our belief that Bradley Caldwell is an ideal partner to help us scale Evolve's presence in core markets where rodent infestations are not only common, but extremely costly; our belief that BCI's trusted relationships and deep penetration into rural retail channels align perfectly with our mission to provide safe, effective, and sustainable rodent control to every corner of the country; our belief that Evolve will now be more accessible in underserved markets; our belief that the partnership with BCI supports our long-term growth strategy, with anticipated revenue increases from expanded retail sales and new customer acquisition; and our belief that the BCI agreement underscores our continued execution on our channel expansion and commercialization roadmap, making Evolve a widely available, easy-to-deploy solution in both professional and consumer markets. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 . All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise .
Contact Information:
Investors:
Robert Blum , Lytham Partners, LLC
(602) 889-9700
senestech@lythampartners.com
Marketing:
Rochelle Paulet , Director of Marketing, SenesTech, Inc.
(928) 779-4143 x814
SOURCE SenesTech, Inc.
-992x558.jpg&w=3840&q=75)
Veckans analyser
.jpg&w=3840&q=75)
-992x558.png&w=3840&q=75)
-992x558.jpg&w=3840&q=75)
Fortnox-budet
-992x558.png&w=3840&q=75)
Veckans analyser
Mest läst
Fortnox-budet
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
-160x160.png&w=3840&q=75)
